Abstract
Amyotrophic lateral sclerosis (ALS) is an incurable degenerative disease. Riluzole can delay disease progression, but its efficacy is limited. Because of lithium’s neuroprotective effects in many animal models, these investigators explored lithium treatment for ALS in a two-part study. In a mouse model of ALS, lithium delayed disease progression and increased life span, compared with saline. Among …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
